INS and polycystic ovary syndrome: Recently, GLP-1 analogs with receptor agonists (RAs) have been studied for treating PCOS, and have shown considerable improvements in insulin sensitivity, reproductive function, weight reduction, and reduced VAT in the PCOS population [14,15,16].